Related Experiment Video
Updated: Feb 11, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Nonsteroidal Antiinflammatory Drugs: A New Generation of Cyclooxygenase Inhibitors
1Bayer AG, Business Group Pharma, PH-R CSP, Aprather Weg 18a, 42096 Wuppertal (Germany), Fax: (+49) 202-36-4064.
Abstract:
The multitalented therapeutic agent that is used to relieve a variety of ailments, acetylsalicylic acid (Aspirin® ) is facing new competition. The goal is to use tailor-made inhibitors of cyclooxygenase-2 to selectively reduce pain while minimizing side effects. Do these new drugs represent a new generation of nonsteroidal pain relievers?
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
05:10Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Related Concept Videos
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...